Hepatitis C Infection and Vasculitis

Infection and Autoimmunity, 2nd edition

Volumn , Issue , 2004, Pages 189-200

  Vassilopoulos, Dimitrios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27944491689     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044451271-0.50016-8     Document Type: Chapter

References (79)

1. Vassilopoulos D, Calabrese LH Virus-associated vasculitides: Clinical aspects. Inflammatory Diseases of the Blood Vessels 2001, 565-597. Marcell Dekker, New York. G.S. Hoffman, C. Weyand (Eds.).
2. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-192.
3. Pioltelli P, Maldifassi P, Vacca A, Mazzaro C, Mussini C, Migliaresi S, et al. GISC protocol experience in the treatment of essential mixed cryoglobulinaemia. Clin Exp Rheumatol 1995, 13 Suppl 13:S187-S190.
4. Lamprecht P, Moosig F, Gause A, Herlyn K, Csernok E, Hansen H, et al. Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis. Ann Rheum Dis 2001, 60:385-390.
5. Ferri C, Zignego AL, Pileri SA Cryoglobulins. J Clin Pathol 2002, 55:4-13.
6. Della RA, Tavoni A, Bombardieri S Cryoglobulinemia. Rheumatology 2003, 1697-1703. Mosby, London. M.C. Hochberg, A.J. Silman, J.S. Smolen, M.E. Weinblatt, M.H. Weisman (Eds.).
7. Lamprecht P, Gause A, Gross WL Cryoglobulinemic vasculitis. Arthritis Rheum 1999, 42:2507-2516.
8. Vassilopoulos D, Calabrese LH Hepatitis C virus infection and vasculitis. Implications of antiviral and immunosuppressive therapies. Arthritis Rheum 2002, 46:585-597.
9. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974, 57:775-788.
10. Alter MJ, Hutin YJ, Armstrong GL Epidemiology of hepatitis. Hepatitis C 2000, 169-183. Academic, San Diego. T.J. Liang, J.H. Hoofnagle (Eds.).
11. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994, 106:1291-1300. [published erratum appears in Gastroenterology 1995 Feb; 108(2):620].
12. Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 1999, 42:2204-2212.
13. Cicardi M, Cesana B, Del Ninno E, Pappalardo E, Silini E, Agostoni A, et al. Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C. J Viral Hepat 2000, 7:138-143.
14. Persico M, De Marino FA, Di Giacomo RG, Persico E, Morante A, Palmentieri B, et al. Prevalence and incidence of cryoglobulins in hepatitis C virus-related chronic hepatitis patients: a prospective study. Am J Gastroenterol 2003, 98:884-888.
15. Donada C, Crucitti A, Donadon V, Tommasi L, Zanette G, Crovatto M, et al. Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinaemia. J Viral Hepat 1998, 5:179-185.
16. Agnello V Mixed cryoglobulinaemia after hepatitis C virus: more and less ambiguity. Ann Rheum Dis 1998, 57:701-702.
17. Gonzalez-Gay MA, Garcia-Porrua C Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. Medicine (Baltimore) 1999, 78:292-308.
18. Agnello V The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 1997, 19:111-129.
19. Rieu V, Cohen P, Andre MH, Mouthon L, Godmer P, Jarrousse B, et al. Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia. Rheumatology (Oxf) 2002, 41:290-300.
20. Dammacco F, Sansonno D, Piccoli C, Tucci FA, Racanelli V The cryoglobulins: an overview. Eur J Clin Invest 2001, 31:628-638.
21. Trejo O, Ramos-Casals M, Garcia-Carrasco M, Yague J, Jimenez S, de la RG, et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medecine (Baltimore) 2001, 80:252-262.
22. Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980, 69:287-308.
23. Dispenzieri A, Gorevic PD Cryoglobulinemia. Hematol Oncol Clin North Am 1999, 13:1315-1349.
24. Crowson AN, Nuovo G, Ferri C, Magro CM The dermatopathologic manifestations of hepatitis C infection: a clinical, histological, and molecular assessment of 35 cases. Hum Pathol 2003, 34:573-579.
25. Daoud MS, el Azhary RA, Gibson LE, Lutz ME, Daoud S Chronic hepatitis C, cryoglobulinemia, and cutaneous necrotizing vasculitis. Clinical, pathologic, and immunopathologic study of twelve patients. J Am Acad Dermatol 1996, 34:219-223.
26. Agnello V, Abel G Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 1997, 40:2007-2015.
27. Mangia A, Andriulli A, Zenarola P, Lomuto M, Cascavilla I, Quadri R, et al. Lack of hepatitis C virus replication intermediate RNA in diseased skin tissue of chronic hepatitis C patients. J Med Virol 1999, 59:277-280.
28. Authier FJ, Bassez G, Payan C, Guillevin L, Pawlotsky JM, Degos JD, et al. Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology 2003, 60:808-812.
29. Lidove O, Cacoub P, Maisonobe T, Servan J, Thibault V, Piette JC, et al. Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinaemia. Ann Rheum Dis 2001, 60:290-292.
30. De Martino L, Sampaolo S, Tucci C, Ambrosone L, Budillon A, Migliaresi S, et al. Viral RNA in nerve tissues of patients with hepatitis C infection and peripheral neuropathy. Muscle Nerve 2003, 27:102-104.
31. Bonetti B, Scardoni M, Monaco S, Rizzuto N, Scarpa A Hepatitis C virus injection of peripheral nerves in type II cryoglobulinaemia. Virchows Arch 1999, 434:533-535.
32. David WS, Peine C, Schlesinger P, Smith SA Nonsystemic vasculitic mononeuropathy multiplex, cryoglobulinemia, and hepatitis C. Muscle Nerve 1996, 19:1596-1602.
33. Origgi L, Vanoli M, Carbone A, Grasso M, Scorza R Central nervous system involvement in patients with HCV-related cryoglobulinemia. Am J Med Sci 1998, 315:208-210.
34. Petty GW, Duffy J, Houston J Cerebral ischemia in patients with hepatitis C virus infection and mixed cryoglobulinemia. Mayo Clin Proc 1996, 71:671-678.
35. Tembl JI, Ferrer JM, Sevilla MT, Lago A, Mayordomo F, Vilchez JJ Neurologic complications associated with hepatitis C virus infection. Neurology 1999, 53:861-864.
36. Beddhu S, Bastacky S, Johnson JP The clinical and morphologic spectrum of renal cryoglobulinemia. Medicine (Baltimore) 2002, 81:398-409.
37. Sabry AA, Sobh MA, Irving WL, Grabowska A, Wagner BE, Fox S, et al. A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol Dial Transplant 2002, 17:239-245.
38. Tarantino A, Moroni G, Banfi G, Manzoni C, Segagni S, Ponticelli C Renal replacement therapy in cryoglobulinaemic nephritis. Nephrol Dial Transplant 1994, 9:1426-1430.
39. D'Amico G Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 1998, 54:650-671.
40. Tarantino A, Campise M, Banfi G, Confalonieri R, Bucci, Montoli A, et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 1995, 47:618-623.
41. Rodriguez-Inigo E, Casqueiro M, Bartolome J, Barat A, Caramelo C, Ortiz A, et al. Hepatitis C virus RNA in kidney biopsies from infected patients with renal diseases. J Viral Hepat 2000, 7:23-29.
42. Sansonno D, Gesualdo L, Manno C, Schena FP, Dammacco F Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 1997, 25:1237-1244.
43. Kayali Z, Buckwold VE, Zimmerman B, Schmidt WN Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 2002, 36:978-985.
44. Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994, 19:841-848.
45. Agnello V Hepatitis C virus infection and type II cryoglobulinemia: an immunological perspective. Hepatology 1997, 26:1375-1379.
46. Zignego AL, Ferri C, Giannelli F, Giannini C, Caini P, Monti M, et al. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 2002, 137:571-580.
47. Zuckerman E, Zuckerman T, Sahar D, Streichman S, Attias D, Sabo E, et al. bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection. Br J Haematol 2001, 112:364-369.
48. Kitay-Cohen Y, Amiel A, Hilzenrat N, Buskila D, Ashur Y, Fejgin M, et al. Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood 2000, 96:2910-2912.
49. Vassilopoulos D, Calabrese LH Rheumatic manifestations of hepatitis C infection. Curr Rheumatol Rep 2003, 5:200-204.
50. Bonomo L, Casato M, Afeltra A, Caccavo D Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med 1987, 83:726-730.
51. Pascual M, Perrin L, Giostra E, Schifferli JA Hepatitis C virus in patients with cryoglobulinemia type II [letter]. J Infect Dis 1990, 162:569-570.
52. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 1991, 9:621-624.
53. Cacoub P, Costedoat-Chalumeau N, Lidove O, Alric L Cryoglobulinemia vasculitis. Curr Opin Rheumatol 2002, 14:29-35.
54. McHutchison JG, Hoofnagle JH Therapy of chronic hepatitis C. Hepatitis C 2000, 203-239. Academic, San Diego. T.J. Liang, J.H. Hoofnagle (Eds.).
55. Donada C, Crucitti A, Donadon V, Chemello L, Alberti A Interferon and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia [letter]. Blood 1998, 92:2983-2984.
56. Calleja JL, Albillos A, Moreno-Otero R, Rossi I, Cacho G, Domper F, et al. Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia. Aliment Pharmacol Ther 1999, 13:1179-1186.
57. Misiani R, Bellavita P, Baio P, Caldara R, Ferruzzi S, Rossi P, et al. Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-alpha and ribavirin. Nephrol Dial Transplant 1999, 14:1558-1560.
58. Zuckerman E, Keren D, Slobodin G, Rosner I, Rozenbaum M, Toubi E, et al. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. J Rheumatol 2000, 27:2172-2178.
59. Garini G, Allegri L, Carnevali L, Catellani W, Manganelli P, Buzio C Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis. Am J Kidney Dis 2001, 38:E35.
60. Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, et al. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 2002, 46:3317-3326.
61. Rossi P, Bertani T, Baio P, Caldara R, Luliri P, Tengattini F, et al. Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy. Kidney Int 2003, 63:2236-2241.
62. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002. Hepatology 2002, 36:S3-S20.
63. Cid MC, Hernandez-Rodriguez J, Robert J, del Rio A, Casademont J, Coll-Vinent B, et al. Inteferon-alpha may exacerbate cryoblobulinemia-related ischemic manifestations: an adverse effect potentially related to its anti-angiogenic activity. Arthritis Rheum 1999, 42:1051-1055.
64. Boonyapisit K, Katirji B Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review. Muscle Nerve 2002, 25:909-913.
65. Ohta S, Yokoyama H, Wada T, Sakai N, Shimizu M, Kato T, et al. Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy. Am J Kidney Dis 1999, 33:1040-1048.
66. Sansonno D, De R, Lauletta G, Tucci FA, Boiocchi M, Dammacco F Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood 2003, 101:3818-3826.
67. Zaja F, De Vita S, Mazzaro C, Sacco S, Damiani D, De Marchi G, et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemi. Blood 2003, 101:3827-3834.
68. Silverman GJ, Weisman S Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. Arthritis Rheum 2003, 48:1484-1492.
69. Boye J, Elter T, Engert A An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab. Ann Oncol 2003, 14:520-535.
70. Cacoub P, Maisonobe T, Thibault V, Gatel A, Servan J, Musset L, et al. Systemic vasculitis in patients with hepatitis C. J Rheumatol 2001, 28:109-118.
71. Costedoat-Chalumeau N, Cacoub P, Maisonobe T, Thibault V, Cluzel P, Gatfosse M, et al. Renal micro-aneurysms in three cases of hepatitis C virus-related vasculitis. Rheumatology (Oxf) 2002, 41:708-710.
72. Cacoub P, Lunel-Fabiani F, Du LT Polyarteritis nodosa and hepatitis C virus infection [letter]. Ann Intern Med 1992, 116:605-606.
73. Carson CW, Conn DL, Czaja AJ, Wright TL, Brecher ME Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993, 20:304-309.
74. Quint L, Deny P, Guillevin L, Granger B, Jarrousse B, Lhote F, et al. Hepatitis C virus in patients with polyarteritis nodosa. Prevalence in 38 patients. Clin Exp Rheumatol 1991, 9:253-257.
75. Vitali C, Galluzzo E, Ciancia EM, Moretti A, Marchi S Giant cell arteritis of the leg in a patient with hepatitis C virus infection. Ann Rheum Dis 1997, 56:697-698.
76. Soufir N, Descamps V, Crickx B, Thibault V, Cosnes A, Becherel PA, et al. Hepatitis C virus infection in cutaneous polyarteritis nodosa: a retrospective study of 16 cases. Arch Dermatol 1999, 135:1001-1002.
77. Disdier P, Pellissier JF, Harle JR, Figarella-Branger D, Bolla G, Weiller PJ Significance of isolated vasculitis of the vasa vasorum on temporal artery biopsy. J Rheumatol 1994, 21:258-260.
78. Genereau T, Martin A, Lortholary O, Noel V, Guillevin L Temporal arteritis symptoms in a patient with hepatitis C virus associated type II cryoglobulinemia and small vessel vasculitis. J Rheumatol 1998, 25:183-185.
79. Ferraccioli GF, Mariuzzi L, Damato R, Rocco M, Pirisi M, Beltrami CA Jaw and leg claudication in a patient with temporal arteritis, chronic sialoadenitis and previous hepatitis C virus infection. Clin Exp Rheumatol 1998, 16:463-468.